An analyst contends that traditional value investors misjudge Palantir (PLTR) by focusing excessively on its valuation, arguing its growth and trading volume align it with the 'Magnificent 7' and that its competitive margins further support this view. The analyst identifies PLTR's high beta and susceptibility to broader market sell-offs as its main risk, rather than its valuation, and anticipates a Q2 earnings beat, partly due to Middle East conflict tailwinds, leading to a 'strong buy' upgrade.
This analyst report presents a strongly bullish thesis for Palantir Technologies Inc. (PLTR), arguing that conventional value investing frameworks focusing on high valuation metrics are inadequate for assessing the company. The analysis positions Palantir as comparable to the 'Magnificent 7' in terms of growth trajectory and trading volume, asserting it ranks second within that cohort on growth metrics. Furthermore, it suggests the company's margins are competitive when adjusted for stock-based compensation (SBC), specifically referencing an anticipated bump in Q4 2024. The primary risk identified is not a valuation-driven collapse but the stock's high beta, which exposes it to significant downside during a broader market selloff. Citing geopolitical tailwinds from the Middle East conflict due to Palantir's ties with Israel, the analyst expects a Q2 earnings beat and has upgraded the stock to a 'strong buy'.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.85
Ticker Sentiment